Natera wins $19 million US verdict from ArcherDX in cancer-detection patent case

By: Blake Brittain

(Reuters) - Genetic testing company Natera Inc convinced a Delaware federal jury on Monday to award it $19.3 million in damages from Invitae Corp's ArcherDX for infringing patents related to cancer detection.

The jury agreed with Natera that biotech company Arche

You are viewing a robot-friendly page.Click hereto reload in standard format.